Yunfeng Capital
Finance · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
no. 1010 Middle Huaihai Rd, Shanghai, Sh...Phone Number
+86 2131270909Website
www.yfc.cnRevenue
$5.9 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
2
About Yunfeng Capital
Our goal is not only to provide capital, but also to share with the portfolio companies the experience and lessons learned, helping them to better formulate corporate strategy, optimize organizational structure and establish brand recognition. We focus on nurturing young entrepreneurs with the potential to become the next-generation industry leaders who can build great companies. We currently manage a number of US Dollar Funds, RMB Funds, as well as Special Funds. Our focus sectors include internet, technology, healthcare, media & entertainment, financial services, logistics and consumer. Yunfeng Capital is headquartered in Shanghai, with offices in Hong Kong, Beijing, Hangzhou, and other cities of China. Our Strengths and HighlightsExplore more
Yunfeng Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Yunfeng Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Yunfeng Capital launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Yunfeng Capital has recently received funding, and reach out quickly before it becomes old news!
Click to see if Yunfeng Capital had a recent Job posting/layoffs
Yunfeng Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Yunfeng Capital is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Yunfeng Capital
Funding: Get notified immidiatlly once Yunfeng Capital has new funding data
Earning: See what the market has to say on Yunfeng Capital recently announced quarterly report
Recommended Actions
Find VP level buyers at Yunfeng Capital
Find 3 more new buyers
Company Profile Activity
Activity Insights
Yunfeng Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Yunfeng Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Yunfeng Capital.
Yunfeng Capital Tech Stack
A closer look at the technologies used by Yunfeng Capital
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Yunfeng Capital News & Media
Ex-Goldman Executive Joins Jack Ma-Backed PE Firm in Tokyo
(Bloomberg) -- A former Goldman Sachs Group Inc. executive in Japan is joining a private equity firm backed by Alibaba Group Holding Ltd. founder Jack Ma, according to a person familiar with the matter.Most Read from BloombergKey Engines of US Consumer Spending Are Losing Steam All at OnceHomebuyers Are Starting to Revolt Over Steep Prices Across USMnuchin Chases Wall Street Glory With His War Chest of Foreign MoneySaudi Arabia Puts Wall Street on Notice toETANA HAS SECURED FINANCING FROM DEG, EAST VENTURES AND OTHER GLOBAL INVESTORS
JAKARTA, Indonesia, March 20, 2023 /PRNewswire/ -- PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Ventures. This round of financing will be used for further strengthening the company's pipeline and portfolio especially in Oncology area to be drug substances manufacturing facilities. Etana is committed to build production capacity for mammalian cell for moETANA HAS SECURED B ROUND FINANCING
JAKARTA, Indonesia, Sept. 28, 2022 /PRNewswire/ -- PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured B round of financing led by Yunfeng Capital and followed by HighLight Capital. This round of financing will be mainly used for further strengthening the company's pipeline & licensing for new products, teams as well as capacity expansions. Etana is leading the development of the Indonesian biopharmaceutical industry and progressing to be the ASEAN leSironax Announces Closing of $200 Million Series B Financing
Financing from new and existing investors will support pipeline progression and expansion for age-related degenerative diseases BEIJING, Aug. 2, 2022 /PRNewswire/ -- Sironax, an emerging biotechnology company dedicated to the discovery and global development of novel treatments for patients with age-related degenerative diseases, today announced the completion of a $200 million Series B financing. The round was led by Gaorong Capital and Yunfeng Capital, with participation from existing investor
Read more news
Top Finance Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Yunfeng Capital
Sign Up For FreeTo access detailed company insights
Our goal is not only to provide capital, but also to share with the portfolio companies the experience and lessons learned, helping them to better formulate corporate strategy, optimize organizational structure and establish brand recognition. We focus on nurturing young entrepreneurs with the potential to become the next-generation industry leader... Read More
